-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, In45igTfwfxKDgAW0eLS8RX52UNkb+TvO7XuGVcZKSFM06b9pdy7BfybS+pXNfmH BinnIRQsaRoswYWdHB9zBg== 0001331514-10-000005.txt : 20101025 0001331514-10-000005.hdr.sgml : 20101025 20101025103931 ACCESSION NUMBER: 0001331514-10-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20101025 DATE AS OF CHANGE: 20101025 EFFECTIVENESS DATE: 20101025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aureon Biosciences, Inc. CENTRAL INDEX KEY: 0001331514 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-149520 FILM NUMBER: 101139040 BUSINESS ADDRESS: STREET 1: 28 WELLS AVE CITY: YONKERS STATE: NY ZIP: 10701 BUSINESS PHONE: 914-377-4000 MAIL ADDRESS: STREET 1: 28 WELLS AVE CITY: YONKERS STATE: NY ZIP: 10701 FORMER COMPANY: FORMER CONFORMED NAME: Aureon Laboratories Inc DATE OF NAME CHANGE: 20050627 D 1 primary_doc.xml X0704 D LIVE 0001331514 Aureon Biosciences, Inc. 28 WELLS AVE YONKERS NY NEW YORK 10701 914-377-4000 DELAWARE Aurigen Bioscience, Inc. Aureon Biosciences Corporation Aureon Laboratories Inc Corporation true Robert Shovlin c/o Aureon Biosciences, Inc. 28 Wells Ave. Yonkers NY NEW YORK 10701 Executive Officer Director Peter Barrett, Ph.D. c/o Atlas Venture 890 Winter Street, Suite 320 Waltham MA MASSACHUSETTS 02451 Director William Burkoth c/o Pfizer Strategic Investments Group 235 E. 42nd Street New York NY NEW YORK 10017 Director Philippe Chambon, M.D., Ph.D. c/o New Leaf Venture Partners, LLC 7 Times Square, Suite 1603 New York NY NEW YORK 10036 Director Carlos Cordon-Cardo, M.D., Ph.D. 1250 First Avenue, Suite 801 New York NY NEW YORK 10021 Director Jose Costa, M.D. 20 York Street East Pavilion, Room 2-607 New Haven CT CONNECTICUT 06520 Director Kevin Johnson c/o Aureon Biosciences, Inc. 28 Wells Ave. Yonkers NY NEW YORK 10701 Director Jose Velasco, M.D. c/o Aureon Biosciences, Inc. 28 Wells Ave. Yonkers NY NEW YORK 10701 Director Biotechnology Decline to Disclose 06 false 2010-10-12 false true true false 0 10000000 4996439 5003561 false 17 0 0 0 false Aureon Biosciences, Inc. /s/ Robert Shovlin Robert Shovlin President and Chief Executive Officer 2010-10-25 -----END PRIVACY-ENHANCED MESSAGE-----